Hemopericardium in a Sirolimus-Treated Renal Transplant Patient

Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be r...

Descripción completa

Detalles Bibliográficos
Autores principales: Groudan, Kevin, Sawalha, Khalid, Bhat, Anusha G, Eltanbedawi, Ahmed, Ambesh, Paurush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458718/
https://www.ncbi.nlm.nih.gov/pubmed/32879829
http://dx.doi.org/10.7759/cureus.9508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458718/
https://www.ncbi.nlm.nih.gov/pubmed/32879829
http://dx.doi.org/10.7759/cureus.9508

Ejemplares similares